Laurus Labs

Research & Development

Research and Development

We are focused on undertaking dedicated R&D in areas, which we believe, have significant growth potential. We believe that our systematic approach to selection of molecules, which involves evaluation of technical, and commercial feasibility data, and customer feedback has resulted in commercialization of 30 out of the 37 filed DMFs. In addition, as of March 31, 2017, the Company owned 41 patents and had applied for 205 patents, in several countries.

Our research team consists of 750 scientists, which constitutes approximately 25.0% of our total employee strength, as of March 31, 2017. We have set up a dedicated R&D center in Hyderabad, which has been operational since 2006, and our kilo lab at this center has been approved by major regulatory authorities including the US FDA, PMDA and KFDA. The latest successful inspection by the US FDA of our R&D center occurred in June 2016. We are currently in the process of expanding our R&D center in Hyderabad and are in the process of setting up another R&D center in Visakhapatnam, Andhra Pradesh. We have also set up an R&D center in Greater Boston, United States in 2015, and as of March 31, 2017, we employed 12 scientists at this center who are focused on strengthening our synthesis business. Further, our R&D center in Hyderabad is approved by the Department of Scientific and Industrial Research, Ministry of Science and Technology of India (“DSIR”) and we have implemented “electronic lab notebook” software to record, integrate, and manage scientific data.

We believe that our R&D has led, and will continue to lead to new, innovative processes that can increase the efficiencies of production including developing cost effective manufacturing processes, as well as address opportunities that we have identified in the global market for our businesses.